The protein kinase pUL97 of human cytomegalovirus plays important but incompletely defined roles in viral replication. Concerning the early phase of infection, it is postulated that pUL97 possesses regulatory functions in gene expression and/or DNA synthesis. Here we report that pUL97 interacts with an essential component of the replication complex, the DNA polymerase processivity factor pUL44. Interaction was determined by yeast two-hybrid and coimmunoprecipitation analyses and was mapped to the pUL97 region 366 -459. In vitro kinase assays demonstrated that pUL44, coimmunoprecipitated either from transfected or from infected cells, is phosphorylated by pUL97 (but not by a catalytically inactive pUL97-mutant). In infected fibroblasts, immunofluorescence analysis revealed that pUL97 and pUL44 accumulate in the nucleus and are both incorporated into viral replication centers. The treatment with inhibitors of DNA synthesis or pUL97 kinase activity largely prevented colocalization. Thus, pUL97 may be indirectly involved in viral genome replication by modifying the replication cofactor pUL44.
Introduction
Human cytomegalovirus (HCMV) infections are a major cause of morbidity and mortality among immunocompromised persons, especially transplant recipients and patients with AIDS. Severe clinical problems also frequently arise from the infection of the fetus. Antiviral agents currently licensed for the treatment of HCMV infection include inhibitors of viral DNA synthesis, such as ganciclovir (GCV), foscarnet (FOS), cidofovir (CDV), and the prodrugs valganciclovir and valacyclovir (reviewed by Curran and Noble, 2001; Lowance et al., 1999) . GCV and related nucleoside analogues are converted by the viral kinase pUL97 into the active monophosphorylated metabolites. This phosphorylation step is therefore confined to virus-infected cells, a prerequisite explaining the specific antiviral action of these compounds. Importantly, it was shown that pUL97, although phosphorylating nucleoside analogues, is not a natural nucleoside kinase (Michel et al., 1996) and might therefore not directly, but possibly indirectly, be involved in the replication processes connected with DNA synthesis. pUL97 belongs to a group of homologous protein kinase C (PKC)-like herpesviral kinases with serine/threonine specificity. Several studies have shown that pUL97 is particularly important for efficient replication (Michel et al., 1996; Prichard et al., 1999; Wolf et al., 2001; Krosky et al., 2003) . Deletion of the UL97 gene in the viral genome was found to be critical for the infection of cultured cells, resulting in a drastic decline in virus replication. As far as the specific function of pUL97 within the viral replication cycle is concerned, it seems suggestive that pUL97 is involved in the activation of phosphorylation-dependent viral regulatory proteins. However, only a limited amount of data has been published concerning the identification of phosphorylated target proteins.
The presented study provides evidence that the protein kinase pUL97 physically interacts with a component of the viral replication complex, the early phosphoprotein pUL44 which is known to stimulate the activity of the HCMV DNA polymerase (Anders and McCue, 1996) . We could demonstrate that pUL44 is phosphorylated by pUL97 in vitro and that both proteins colocalize within replication centers in the nuclei of infected cells. These findings might indicate the importance of pUL44 -pUL97 interaction for early replication steps.
Results

pUL97 physically interacts with pUL44 in the yeast twohybrid assay
Although the expression and activity of the HCMV protein kinase pUL97 have been investigated in detail, the identification of phosphorylated target proteins is still a matter of controversial discussion. Recently, however, the UL44 protein was proposed as a putative natural substrate of the viral kinase, possibly referring to the role of pUL97 in the early phase of infection. In a congress report by Krosky et al. , the in vitro phosphorylation of purified recombinant pUL44 by pUL97 was demonstrated (24th International Herpesvirus Workshop, Boston, 1999; P. Krosky, personal communication) . Therefore, we performed a yeast two-hybrid analysis to address the question of interaction between the two viral proteins. pUL44 (in fusion to activation domain GAL4AD) was coexpressed with pUL97 (in fusion to DNA binding domain GAL4BD) (Fig. 1a, top) . When assayed for ␤-Gal activity by filter lift tests, a specific subset of clones stained dark blue, indicative of interaction. Furthermore, a catalytically inactive point mutant of pUL97 (K355M) was likewise positive, indicating that the kinase activity, in particular autophosphorylation of pUL97, was not required for interaction. Then, the specificity of protein interaction was further analyzed by testing a series of HCMV-encoded as well as heterologous viral proteins for interaction with pUL97 (Fig. 1a, middle and bottom ). Another component of the HCMV replication complex, the single-stranded DNA-binding protein pUL57, clearly stained negative in coexpression with pUL97, tested in fusion to both GAL4AD and GAL4BD. Furthermore, pUL57 did not interact with pUL44 in the yeast two-hybrid system (data not shown). Other HCMV proteins, such as pUL84, IE2p86, pUL69, pp65, pp150, pUL26, and pUL97 itself, as well as heterologous viral proteins, such as EBNA1 and SV40-T, were also negative for interaction with pUL97. With respect to the findings described for Fig. 3 concerning intracellular localization, it should be mentioned that several of these proteins were found to be associated with subnuclear compartments, such as viral replication centers or ND10 domains, e.g., pUL44 (Sarisky and Hayward, 1996; Yamamoto et al., 1998) , pUL57 (Ahn et al., 1999) , pUL84 (Xu et al., 2002) , and IE2p86 (Ahn and Hayward, 1997; Hofmann et al., 2002) . This might be highly relevant for the localization of pUL97 itself (see below). Combined, these findings show that among a series of viral proteins tested for interaction with pUL97, only pUL44 resulted in positive signals, strongly suggesting the specificity of interaction.
In a second approach, we generated a series of deletion mutants of pUL97 to map the region which is responsible for interaction with pUL44 (Fig. 1b) . As determined by two independent methods (filter lift and ONPG assays), ␤-galactosidase (␤-Gal) positive clones were obtained for all mutants containing the central portion of pUL97, whereas those mutants lacking the central region were negative. C-terminal deletion of pUL97 up to position 459 did not prevent interaction and also N-terminal deletion up to position 366 was tolerable. The results obtained by filter lift staining were supported by those obtained by the ONPG assay. In conclusion, the interaction with pUL44 is mediated by the central region of pUL97 spanning amino acids 366 to 459. It is noteworthy that this region is distinct from other protein interaction domains of pUL97. We recently identified two cellular interactors of pUL97 and these two proteins contact the regions adjacent to the pUL44 interaction domain (M. Marschall, unpublished data).
pUL44 is coimmunoprecipitated with pUL97 from infected or transfected cells
Given the information from the yeast two-hybrid system, we first investigated whether interaction between pUL97 and pUL44 was detectable in HCMV-infected human fibroblasts. Infection was performed at high as well as at low m.o.i., and mock-infected cells served as a negative control. Lysates from these samples were used for immunoprecipitation with a monoclonal antibody against pUL44 (Fig. 2a) . When analyzed by Western blotting, specific coimmunoprecipitation of pUL97 was detected in samples from high m.o.i., but no signals were obtained in samples from mockinfection or low m.o.i. With respect to the lack of signals under low m.o.i., it should be taken into consideration that production of both proteins was quantitatively limited (see infection control). In addition, all samples used for immunoprecipitation with a nonspecific control antibody were also negative for pUL97. Thus, pUL97, at least in part, is complexed with pUL44 in HCMV-infected fibroblasts.
In addition to that, an experiment was performed to exclude the possibility of an indirect interaction mediated by other viral proteins. For this, we overexpressed pUL97 and pUL44 in 293T cells as fusion proteins with C-terminal HA or FLAG tags, respectively. When putative complexes were immunoprecipitated by MAb-HA and subsequently analyzed on a Western blot by the use of MAb-FLAG, we detected interaction between pUL97 and pUL44 (but not pUL84, which was chosen as a specificity negative control). Thus, although we cannot exclude the possibility of an indirect interaction through a cellular bridging protein, it is unequivocal that the pUL97-pUL44 interaction occurs in the absence of other viral proteins.
Colocalization of pUL97 with pUL44 in nuclear replication centers
Infected fibroblasts were analyzed by immunofluorescence double staining to visualize viral protein complexes on the single-cell level (Fig. 3a) . In a kinetic study, covering Fig. 1 . Interaction between pUL97 and pUL44 in the yeast two-hybrid system. (a) Yeast strain Y153 was transformed with constructs pAS-UL97 and pACT-UL44, or empty vectors as a control. The catalytically inactive mutant K355M of pUL97 was compared to wild-type and the specificity of interaction was illustrated by the use of a series of expression constructs for other viral proteins (expressed in fusion to either GAL4BD or GAL4AD, as indicated). The constructs expressing simian virus 40 large T antigen (SV40-T) or tumor suppressor protein (p53) were used as a positive control for interaction. Staining of clones by the filter lift assay (␤-Gal activity) is shown and the results were reproduced by at least two independent experiments (ϩ, ␤-Gal positive; Ϫ, ␤-Gal negative). (b) The interaction region within pUL97 was mapped by the use of C-terminal and N-terminal deletion mutants. pUL44 was coexpressed in its wild-type form. Signals of interaction were determined by two independent methods, the filter lift and the ONPG assay. ␤-Gal positive clones are pictured as blue colonies and quantified by relative ONPG values (1.00 means full reactivity between pUL44 and pUL97 wild-type). Cell lysates were prepared at 3 days postinfection. The success of infection was monitored by the analysis of small aliquots on Western blots using HCMV-specific monoclonal antibodies as indicated (infection control). Lysates were used for immunoprecipitation with monoclonal antibodies reactive for pUL44 (MAb-UL44) or nonreactive for pUL44 (MAb-FLAG as a negative control). The coimmunoprecipitation of pUL97 was detected on Western blots by the use of MAb-UL97 (with specific bands marked by arrowheads). The strong background staining in the lower part of the blot is due to a reactivity of the secondary antibody (HRP-coupled anti-mouse) against the heavy chain of the precipitation antibodies (mouse MAbs, Ig-HC). Marker bands: 205, 116, 97.4, 68, 45, 29 kDa. (b) 293T cells were cotransfected with the indicated combinations of constructs expressing tagged versions of pUL97, pUL44, or pUL84, and GFP served as a control. Specific precipitation of pUL97 was achieved by the use of MAb-HA and the coprecipitated pUL44 was detected on a Western blot using MAb-FLAG. Expression of all proteins was controlled either by fluorescence microscopy (GFP) or Western blot analysis of lysate controls taken prior to coimmunoprecipitation (MAb-HA and MAb-FLAG, not shown).
immediate early (12 h), early (24 -48 h), and late (72 h) phases of HCMV infection, the intensifying colocalization of pUL97 with pUL44 was demonstrated. At time points earlier than 24 h, only slight staining in diffuse localizations was obtained for both proteins (data not shown). In the early phase, from 24 to 48 h, pUL44 accumulated in intranuclear granules. Subsequently, this staining pattern steadily converted into the fine-structured and defined viral replication centers (Ahn et al., 1999; Giesen et al., 2000) . As an additional marker for the formation of replication centers (Yamamoto et al., 1998; Ahn et al., 1999) , a costaining between the viral DNA-associated accessory protein pUL112-113 and pUL44 was performed (data not shown). pUL97, on the other hand, initially occurred in a homogeneous nuclear distribution which, to an increasing degree, altered toward a distinct colocalization with pUL44. It seemed that pUL44 preceded the localization in replication centers, while pUL97 only partly colocalized with these subnuclear structures early during infection. At 72 h, however, this picture completely changed in a way that pUL97 accumulated within replication centers and showed a strong colocalization with pUL44 ( Fig. 3a , panels i-m, at higher magnification, n-q). This finding is consistent with the data obtained by coimmunoprecipitation at 72 h postinfection (see .
In addition, an experiment was performed with a virus variant that carries a point mutation in pUL97 (M460I). This mutation confers viral GCV resistance and lowers, but does not completely prevent, pUL97 protein kinase activity (Marschall et al., 2001) . In this case again, a distinct pattern of colocalization between pUL97(M460I) and pUL44 in replication centers was obtained. Therefore, we conclude that, starting with the early phase of HCMV infection, pUL97 wild-type as well as a GCV-resistant mutant, associates with pUL44 within viral nuclear compartments.
We further addressed the question of whether the protein kinase activity of pUL97 was functionally connected with this interaction (Fig. 3b ). For this, we analyzed the effect of inhibitors of viral DNA synthesis (CDV) and pUL97 kinase activity (NGIC-I and Gö6976) on the formation of replication centers. CDV, a therapeutically important nucleotide analogue blocking viral DNA synthesis, prevented the formation of replication centers and the distinct colocalization between pUL97 and pUL44. Importantly, a similar effect was noted for NGIC-I and Gö6976 (indolocarbazoles), which were recently described as potent anticytomegaloviral compounds effecting a drastic reduction of the in vitro replication efficiency at the stage of pUL97 (Marschall et Fig. 3 . Colocalization of pUL97 and pUL44 in nuclear replication centers. (a) HFFs were infected with HCMV strain AD169 at an m.o.i. of 0.1 and harvested at the time points indicated. Fixed cells were double-stained for the production of viral proteins using antibodies against pUL97 (rabbit anti-UL97) and pUL44 (mouse MAb-UL44) in a combined incubation. Secondary antibodies were used for staining pUL97 in green (anti-rabbit-FITC) and pUL44 in red (anti-mouse-Cy3). Colocalization was visualized by a merge of the two microscopic determinations. Counterstaining of the cell nuclei was achieved by the use of DAPI. Arrows indicate the appearance of viral replication centers (magnification, ϫ400). Panels n to q show an enlarged image of one infected nucleus at 72 h (magnification, ϫ630). Panels r to u show a virus mutant, carrying a GCV resistance-conferring point mutation in UL97 (M460I). (b) HFFs were infected with HCMV strain AD169 at an m.o.i. of 0.1 and various inhibitors were added to the culture medium after incubation with the inoculum virus at the concentrations indicated (CDV, inhibitor of viral DNA synthesis; NGIC-I and Gö6976, protein kinase inhibitors targeting pUL97; Gö7874 and AG490, non-pUL97-specific protein kinase inhibitors). Infected cells were harvested at 4 days postinfection and used for double-staining as described above. Zimmermann et al., 2000) . In comparison, two other protein kinase inhibitors (Gö7874 and AG490), lacking specificity for pUL97, did not show an effect on the pUL97-pUL44 colocalization pattern. Thus, the finding suggests that these inhibitors of the pUL97 kinase activity prevent the formation of replication centers.
pUL97 phosphorylates pUL44 after precipitation from transfected or infected cells
The interaction and colocalization of pUL97 with pUL44 raised the question of whether pUL44 was phosphorylated by pUL97 during this process. We performed transfection experiments and immunoprecipitation of the produced proteins to analyze the precipitates in an in vitro kinase assay (Fig. 4a-f) . By doing so, it became evident that pUL44 is already phosphorylated to a limited degree when precipitated alone in the absence of pUL97. This might be due to a yet unknown cellular protein kinase, exerting this activity after unwarranted coprecipitation from the cell lysates. In the presence of pUL97, however, phosphorylation of pUL44 was strongly increased and was detected in the form of a phosphorylated pUL44 double-band (Fig. 4a) . In addition, the double-band specific for pUL97 autophosphorylation (see also Marschall et al., 2002) proved the desired activity of the viral kinase in these samples. Expression controls were obtained by assaying aliquots of the cell lysates on Western blots to prove the production of adequate amounts of pUL97 and/or pUL44 after transfection (Fig. 4b , c, and e). This finding was further illustrated by the comparison of in vitro kinase assays containing active versus inactive pUL97 (Fig. 4d, left) . pUL44 was strongly phosphorylated only in the presence of wild-type pUL97, but was poorly phosphorylated (close to background level, compare lane 2 of d with lane 1 of a) by using the catalytically inactive point mutant pUL97(K355M). In a similar fashion, the extent of pUL44 phosphorylation was largely reduced by an incubation with the pUL97-directed inhibitor NGIC-I (Fig. 4d, right) . Thus, pUL44 expressed upon transfection is a specific substrate of the coexpressed pUL97 kinase. Phosphorylation is clearly dependent on the activity of pUL97 protein kinase, but cellular kinases may also contribute to full phosphorylation of pUL44 in vivo.
The specificity of phosphorylation reactions was monitored by the use of control samples (Fig. 4f) . When histone 2B, known as an in vitro substrate of pUL97 (Marschall et al., 2001; Baek et al., 2002b) , was added to the precipitated pUL97 kinase, it was clearly phosphorylated. However, the addition of immunoprecipitated FLAG-tagged HCMV proteins other than pUL44, such as pUL84, IE2p86 (amino acids 135-579), or pUL26, did not result in phosphorylation. It should be noted that for IE2p86 and pUL84, the phosphorylation in HCMV-infected cells is known or postulated (Harel and Alwine, 1998; Xu et al., 2002 ; reviewed by Mocarski and Courcelle, 2001) .
In a next step, it should be demonstrated that this phosphorylation event is likewise detectable expressed proteins from infected cells (Fig. 4g-i ). HFFs were infected with two strains of HCMV (laboratory reference strain AD169 and the endotheliotropic strain TB40E); lysates were prepared after 3 days and used for the precipitation of pUL97 under coimmunoprecipitation conditions. The putative protein complexes were directly assayed in the in vitro kinase assay.
As an essential result, the characteristic autophosphorylation signal of pUL97 was strongly detectable in the samples derived from AD169 as well as TB40E infection, but not from mock infection (Fig. 4g) . Furthermore, an additional phosphorylated band became visible and thus strongly argued for the successful coimmunoprecipitation of a phosphorylation substrate (which was absent from the control panel showing the non-specific precipitation with preimmune serum). The coimmunoprecipitates were further analyzed on Western blots ( Fig. 4h-i) . Hereby, the staining was positive, both for pUL97-as well as pUL44-specific MAbs, indicating the pUL97-pUL44 coimmunoprecipitation. For pUL44, at least three bands were detectable under these conditions, whereby the largest band most likely corresponds to the phosphoprotein identified in Fig. 4g . The Western blot pattern of UL44 products relates to findings in other infection experiments, where a single pUL44-specific polypeptide of 55 kDa was characteristic for the early phase of infection, but more bands were detected at later time points. Thus, we confirmed that pUL44 is coprecipitated with pUL97 from lysates of HCMV-infected fibroblasts. Furthermore, the phosphorylation data derived from these coimmunoprecipitates are consistent with the hypothesis that pUL44 is phosphorylated by pUL97 in vivo.
Discussion
In this study, we provide four lines of evidence illustrating the interaction between pUL97 and pUL44 of HCMV: (i) a physical interaction of the two viral proteins was demonstrated by the yeast two-hybrid system and coimmunoprecipitation analyses using infected or transfected cells; (ii) the pUL97 region (amino acids 366 to 459), responsible for interaction with pUL44, was mapped by C-terminal and N-terminal deletion mutagenesis; (iii) a distinct colocalization was identified in nuclear replication compartments of infected fibroblasts; and finally (iv), the phosphorylation of pUL44 by the pUL97 protein kinase was shown with coimmunoprecipitated proteins in the in vitro kinase assay. This indicates that pUL97 associates with pUL44 in the viral replication complex, phosphorylates this essential factor, and thus might possess a coregulatory role in viral genome replication.
The specific role of pUL97 in the viral replication cycle has only partly been elucidated so far. Generally, the protein kinase activity of pUL97 seems to be required for a high efficiency of viral replication (Prichard et al., 1999; Michel et al., 1996) . A publication by Wolf et al. (2001) showed Fig. 4 . Phosphorylation of pUL44 by pUL97 after coimmunoprecipitation from transfected or infected cells. (a-f) 293 cells were transfected with plasmids for the expression of pUL44, pUL97, or both (pcDNA-UL44-FLAG, pcDNA-UL97-FLAG, pcDNA-UL97(K355M)-FLAG, or pcDNA3.1 for mock control). Two days posttransfection, cells were harvested, used for the preparation of cell lysates, and subjected to immunoprecipition with MAb-FLAG. Precipitates were incubated in the UL97 in vitro kinase assay (IVKA) and phosphorylation products were visualized after SDS-PAGE separation and exposure to autoradiography (a). Autophosphorylation of pUL97 and phosphorylation of pUL44 is indicated by arrowheads. Note the faint phosphorylation band of pUL44 in the first lane and the strongly increased phosphorylation of pUL44 in the presence of pUL97 in the second lane. The high level of expression in transfected cells was verified by analysis of small aliquots of the lysates prior to immunoprecipitation on Western blots using HCMV-specific antibodies, i.e., anti-UL97 (b) or MAb-UL44 (c), respectively. (d) Phosphorylation of pUL44 derived from coimmunoprecipitation with pUL97 wild-type was compared to that derived from mutant pUL97(K355M) (left) or that under treatment with the pUL97 inhibitor NGIC-I (100 nM; right). (e) Expression was controlled on Western blots as decribed above (MAb-UL44). (f) As a specificity control panel, several proteins were subjected to the UL97 in vitro kinase analysis. Histone 2B (H2B) was added directly to the kinase reaction in the form of a purified protein, while HCMV proteins pUL84, IE2p86, and pUL26 were coexpressed as FLAG-tagged versions in transfected cells as described above, precipitated, and assayed in the presence of pUL97. (g-i) HFFs were infected with HCMV strains AD169 or TB40E at an m.o.i. of 0.5 or remained mock-infected. Cell lysates were prepared at 3 days postinfection. Lysates were used for immunoprecipitation with a rabbit antiserum reactive for pUL97 (anti-UL97) or nonreactive for pUL97 (preimmune serum as a negative control) under the conditions described for coimmunoprecipitation. Putative complexes were subjected to the pUL97 in vitro kinase assay and radioactive phosphorylation products were detected by SDS-PAGE separation and exposure to autoradiography (g). The proteins labeled in the pUL97 in vitro kinase assay were further characterized by Western blot analysis using HCMV-specific antibodies, i.e., MAb-UL44 (h) or MAb-UL97 (i), respectively. Note that for pUL44, at least three specific bands are detectable in 3-day infected fibroblasts, while only the upper band appears as phosphorylated form in the IVKA panel. that pUL97 acts both at early and at late steps of viral replication. During the early phase, pUL97 is responsible for the efficiency of viral DNA synthesis, as illustrated by the analysis of a UL97-deleted virus mutant. The mutant was characterized by reduced viral DNA synthesis and accumulation, showing absence of a well-synchronized DNA cleavage activity. Furthermore, an important part of the functional role of pUL97 is also developed during the late phase of infection and might be directed to viral capsid assembly. Viral capsid maturation, particularly the phase of nuclear egress of capsids, was very inefficient in the case of infection with the UL97-deleted virus mutant, finally leading to an intranuclear capsid accumulation (Krosky et al., 2003; Wolf et al., 2001 ). The intracellular localization of pUL97 is mostly nuclear with some cytoplasmic signals becoming visible with increasing time of infection (Michel et al., 1996) . Although the nuclear localization signal of pUL97 was mapped (Michel et al., 1998) and, in addition to that, signs of perinuclear accumulation of pUL97 were reported (Marschall et al., 27th International Herpesvirus Workshop, Cairns, Australia, 2002; Michel et al., 1996) , to our knowledge this is the first study clearly demonstrating the compartmentalization of this protein in viral nuclear replication centers. Despite the fact that we demonstrated a direct interaction of pUL97 with pUL44, it cannot be ruled out entirely that additional viral or cellular proteins play a role for this distinct subcellular localization pattern. However, the finding that pUL97 phosphorylates pUL44, a prominent component of the replication complex, tempts to postulate an involvement of pUL97 in the early process of viral DNA synthesis. Particularly, the pUL97-specific coimmunoprecipitation of functional complexes from HCMVinfected fibroblasts, containing the activity to phosphorylate coprecipitated pUL44, substantiates this concept. Thus, as concluded from this study and from several previous reports, the functional aspects of pUL97 are complex. They can in part be explained by the association of pUL97 with the viral replication machinery, possibly possessing an impact on viral DNA synthesis and, in other parts, by the involvement of pUL97 in processes which occur later during infection.
As far as the definition of natural substrates of pUL97 is concerned, little clear evidence for the phosphorylation events during HCMV infection has been provided, but the phosphorylation in vitro was described for a small number of proteins. The phosphorylation of histones was reported by several investigators (He et al., 1997; Marschall et al., 2001 Marschall et al., , 2002 Baek et al., 2002b; reviewed by Shugar, 1999) . In a recent study by Baek et al. (2002b) , the importance of specific amino acids (arginine or lysine), five positions downstream from one of the phosphorylated target residues (serine) for the efficiency of histone 2B phosphorylation, was described in detail. In this context, it was speculated that HCMV might regulate gene expression through the mechanism of histone phosphorylation and chromatin condensation, but this possibility awaits further experimental evidence.
Another important feature is the autophosphorylation of pUL97. Autophosphorylation was observed with pUL97 expressed from recombinant baculovirus (He et al., 1997) , vaccinia virus (Michel et al., 1996) , plasmid vectors (Marschall et al., 2001) , as well as with pUL97 isolated from virions and infected cells (Wolf et al., 1998; van Zeijl et al., 1997) . Since natural virus mutants, lacking pUL97 autophosphorylation activity, have not been described and point mutants in UL97 (e.g., ganciclovir resistance mutants) sometimes possess reduced, but in all cases detectable, levels of pUL97 autophosphorylation, it is suggestive that this activity is important for efficient viral replication. It was postulated that pUL97 autophosphorylation is a prerequisite of ganciclovir phosphorylation, based on the analysis of a series of cloned autophosphorylation-negative and -positive mutants of pUL97 (Michel et al., 1999) . Our data confirm and extend this statement into the activity of protein phosphorylation, since we found that deletions within pUL97 abrogating autophosphorylation led to a complete loss of histone 2B phosphorylation (M. Marschall, unpublished data). In a very recent publication by Baek et al. (2002a) , however, specific deletion mutants were described, e.g., pUL97 ⌬N239, which retained a high degree of histone 2B phosphorylation, despite a largely reduced autophosphorylation activity. This might indicate that a wild-type level of autophosphorylation is not required for the phosphorylation of exogenous substrates. Alternatively, autophosphorylation could be involved in protein-protein interactions. Interestingly, in our studies neither the C-terminal deletion mutants pUL97 (1-595), pUL97 (1-523), and pUL97 (1-459), which all lack autophosphorylation activity (data not shown), nor the catalytically inactive mutant pUL97(K355M), are impaired in the interaction with pUL44 (see yeast two-hybrid data, Fig. 1a and b) . Thus, it will be interesting to see whether further activities of pUL97, such as pUL44 phosphorylation, are dependent on autophosphorylation.
There are several similarities between the function of pUL97 and homologous proteins encoded by other herpesviruses. UL97 homologs were identified in all eight human herpesviruses and the encoded proteins belong to a group of PKC-related serine/threonine-specific protein kinases (Chee et al., 1989; Smith and Smith, 1989; Purves and Roizman, 1992; Ng and Grose, 1992; Littler et al., 1992; Michel et al., 1996; Ansari and Emery, 1999; Park et al., 2000) . Some of these kinases are also capable of phosphorylating nucleosidic substrates, such as GCV, in addition to their natural protein substrates. This has been proven first for HCMV pUL97 (Littler et al., 1992; Sullivan et al., 1992) , a finding that explained the virus' GCV sensitivity in the absence of a virus-encoded thymidine kinase. Other human herpesviruses, such as Epstein-Barr virus (EBV), also show GCV sensitivity during lytic replication, but although a virusencoded thymidine kinase exists, GCV phosphorylation seems to be mediated (in a way similar to HCMV) primarily by the viral protein kinase, BGLF4 (Gustafson et al., 1998; Marschall et al., 2002) . BGLF4 performs autophosphorylation (similar to pUL97) and phosphorylates at least one further viral target protein, the DNA polymerase processivity factor BMRF1 (Chen et al., 2000) . BMRF1 is homologous to HCMV pUL44 and exists in multiple phosphorylated forms. It was postulated that massive phosphorylation of BMRF1 might be associated with enhanced protein stability (Zacny et al., 1999) . It should be mentioned that the phosphorylation of BMRF1, similar to our findings for pUL44, is mediated mainly but not exclusively by the virusencoded protein kinase. Phosphorylation by cellular protein kinases may play an additional role (Zacny et al., 1999) . The investigation of compounds inhibiting the phosphorylation of BMRF1, such as the L-riboside benzimidazole 1263W94, confirmed the idea on the combined action of viral and cellular kinases: treatment with 1263W94 suppressed the hyperphosphorylation of BMRF1 in lytically induced EBVpositive cells. Surprisingly, however, inhibition occurred at a level other than the direct block of the BGLF4 protein kinase activity. Thus, the involvement of a cellular kinase seems suggestive. Moreover, the findings for 1263W94 are distict from our results for the indolocarbazole NGIC-I: this strong inhibitor of HCMV replication possesses high specificity for the virus-encoded protein kinase pUL97, lacking activity against other kinases (such as BGLF4; Marschall et al., 2002) . Concludingly, NGIC-I may block essential steps in the pUL97 substrate phosphorylation (e.g., pUL44 phosphorylation), which most probably represents the mechanism of virus inhibition.
Our findings provide evidence that pUL97 physically interacts, phosphorylates, and colocalizes with pUL44 in viral replication compartments. Since it is known that pUL44 acts as a processivity factor stimulating the activity of the HCMV DNA polymerase pUL54, we assume that phosphorylation of pUL44 might contribute to the regulation of DNA synthesis. Thus, pUL97 is involved in essential early functions of viral genome replication and represents a target whose activities are accessible for the specific interference by antiviralagents.
Materials and methods
Cell culture
Primary human foreskin fibroblasts (HFFs), 293, and 293T cells were cultivated in minimal essential medium (MEM) or Dulbecco's MEM, respectively, containing 5% fetal bovine serum and 100 g/ml gentamicin. HCMVs AD169 (laboratory strain) and TB40E (endotheliotropic strain) were propagated in HFFs and used for infection experiments under standard conditions. Transfection of 293 and 293T cells was performed by the Lipofectamin Plus method (Invitrogen) in 10-cm dishes at a cell confluency of 75%.
Construction of expression plasmids
Expression constructs were generated with vectors pcDNA3.1 (Invitrogen), pGBT9, pGAD424 (Clontech), pACT, and pAS1 (Durfee et al., 1993) . pcDNA-UL97-FLAG, pcDNA-UL97-HA, and pcDNA-UL97(K355M)-FLAG had been described elsewhere (Marschall et al., 2001) . Note that the mutant pUL97(K355M) is catalytically inactive due to an amino acid exchange at the invariant lysine 355 of the ATP binding site. pAS-UL97, pACT-UL97, and pAS-UL97(K355M) were constructed in a similar way by the insertion of the respective UL97 sequence into vectors pAS1 and pACT. Ten deletion mutants of UL97 were generated by the production of PCR amplificates from template pcDNA-UL97 using the primers listed below and subsequent insertion into vector pGBT9. PCR was performed using Vent DNA polymerase (New England BioLabs) in 35 cycles, each composed of 40 s at 95°C for denaturation, 40 s at 50°C for annealing, and 120 s at 72°C for polymerization. Likewise, ORF-UL44 was amplified using genomic DNA of HCMV strain AD169 as a template and cloned into vector pACT to construct pACT-UL44. For generating pcDNA-UL44-FLAG, ORF-UL44 was cloned in fusion to the C-terminal FLAG sequence of the modified vector pcDNA3.1-FLAG (GACTACAAAGACGATGAC-GACAAG). For pcDNA-UL84-FLAG, pcDNA-UL26-FLAG, and pcDNA-IE2p86(135-579)-FLAG, full-length ORFs (or partial sequences spanning the amino acids indicated) were cloned in fusion to the N-terminal FLAG sequence. pCmn-GFP is a green fluorescent protein (GFP) encoding construct of the vector pCMV/myc/nuc (Invitrogen) used as a standard transfection control for human cells. As a control for yeast two-hybrid experiments, a series of constructs was used which allowed for the expression of the HCMV ORFs UL57, UL84, UL122 [IE2p86(135-579); Hofmann et al., 2000] , UL69 (Winkler et al., 2000) , UL83 (pp65), UL32 (pp150), and UL26 in fusion to either GAL4AD or GAL4-BD of the vectors listed above. A yeast expression construct for ] was kindly provided by Dr. N. Fischer (Fischer et al., 1997) . Two commercially available expression constructs (Clontech) were used as a positive control for the protein interaction in yeast, pTD1 (SV40-T) and pVA3 (p53).
Oligonucleotides
Synthetic oligonucleotide primers for PCR were purchased from Sigma. UL97-specific sequences are underlined. Restriction sites are bold-printed and the FLAG sequence is indicated by italics: 5Ј-UL97-1-EcoRI: (TAGT GAA TTC ATG TCC TCC GCA CTT CGG TCT CGG) 5Ј-UL97-49-EcoRI:
(TAGT GAA TTC ATG GCG GTG CAG GCC GCG CAG GCC) 5Ј-UL97-111-EcoRI: (TAGT GAA TTC ATG CGT GAC GGA GAA AAA GAG GAC GCG GCT) 5Ј-UL97-181-EcoRI: (TAGT GAA TTC ATG GAC CCC TCG GAC AGC GTG AGC GGC) 5Ј-UL97-366-EcoRI: (TAGT GAA TTC ATG ACG GTC TGG ATG TCG GGC CTG ATC CGC ACG) 3Ј-UL97-110-SaII-FLAG: (CCG GTC GAC TTA CTT GTC GTC ATC GTC TTT GTA GTC CAC GTC ACT TCG AAC GCA TGC G) 3Ј-UL97-180-SaII-FLAG: (CCG GTC GAC TTA CTT GTC GTC ATC GTC TTT GTA GTC GCT GCC GCC GGT GAA GAG AGC) 3Ј-UL97-365-SaII-FLAG: (CCG GTC GAC TTA CTT GTC GTC ATC GTC TTT GTA GTC GAG CAC CGT CTC GCT GTG CTT ACG C) 3Ј-UL97-459-SaII-FLAG: (CCG GTC GAC TTA CTT GTC GTC ATC GTC TTT GTA GTC GGG TGT AAT GTC AAA GTG GCA TAC ACG) 3Ј-UL97-523-SaII-FLAG: (CCG GTC GAC TTA CTT GTC GTC ATC GTC TTT GTA GTC GAA AGC AGG GTG GTA ACA TTC GCG) 3Ј-UL97-595-SaII-FLAG: (CCG GTC GAC TTA CTT GTC GTC ATC GTC TTT GTA GTC CAA CGC GCG GCA GGC CGC GC) 3Ј-UL97-707-SaII-FLAG: (CCG GTC GAC TTA CTT GTC GTC ATC GTC TTT GTA GTC CTC GGG GAA CAG TTG GCG GCA)
Yeast two-hybrid analysis
Protein interactions were analyzed by the use of GAL4 fusion proteins in a standard yeast two-hybrid protocol (Fields and Song, 1989) including minor modifications. Saccharomyces cerevisiae strain Y153 was transformed by the lithium acetate method (Gietz et al., 1992) using plasmid pAS-UL97 to express pUL97-GAL4BD as a bait. As putative interactors, pUL44 and several control proteins were expressed as GAL4AD fusion proteins. Expression was confirmed by Western blotting using the monoclonal antibodies MAb-GAL4BD and MAb-GAL4AD (Clontech, Heidelberg). The presence of both or either of the two plasmids was stably maintained by growth selection for combined tryptophan/leucine prototrophy or a single prototrophy, respectively. Primary transformants were further selected for growth on histidine-deficient plates (indicating protein interaction) containing 30 mM 3-aminotriazole. His-competent clones were analyzed for ␤-Gal activity by filter lift tests. The interaction was then quantified by o-nitrophenyl galactopyranoside (ONPG) assays as described elsewhere (Guarente, 1983) .
Coimmunoprecipitation analysis
HFFs were infected with HCMV strain AD169 at m.o.i.s of 1, 0.1, and 0 as an uninfected control (approximately 5 ϫ 10 6 cells per coimmunoprecipitation sample). Three days postinfection, cells were harvested by trypsinization, lysed in 1 ml of CoIP buffer (50 mM Tris-HCl pH 8.0, 150 nM NaCl, 5 mM EDTA, 0.5% NP-40, 1 mM PMSF, 2 g/ml aprotinin, 2 g/ml leupeptin, and 2 g/ml pepstatin) and used for immunoprecipitation. For this, 4 l of a monoclonal antibody, e.g., MAb-UL44 (supplied by B. Plachter, Univ. Mainz, Germany), or a non-UL44-reactive MAb as a control was incubated for 4 h at 4°C under rotation, before protein A-sepharose beads (Amersham, Pharmacia Biotech; 2.5 mg in a 50-l volume of CoIP buffer) were added for complexation. The complexes were pelleted in an Eppendorf centrifuge (5000 rpm, 2 min), washed four times with ColP buffer, and denturated in 50 l of boiling mix buffer. Samples were heat-denatured for 10 min at 95°C and used for separation on 12.5% SDS-PAGE. Thereafter, gels were subjected to a standard Western blotting procedure and analyzed by the use of MAb-UL97 (supplied by D. Michel, Univ. Ulm, Germany) for the coimmunoprecipitation of pUL97. Staining was performed by the enhanced chemiluminescence (ECL) method according to manufacturer's protocol (New England Biolabs). Alternatively, for the coimmunoprecipitation of two tagged viral proteins (FLAG-or HA-tagged, respectively) in the absence of HCMV replication, 293T cells were transfected with two expression constructs and lysed 2 days posttransfection, and lysates were subjected to the procedure described above using of 2 l MAb-HA (HA.11; BAbCO, Richmond, CA, USA).
Indirect immunofluorescence test
HFFs were grown on coverslips in six-well plates and infected with HCMV strain AD169 at an m.o.i. of 0.1. Four days postinfection, cells were washed twice with PBS and used for fixation with ice-cold methanol for 10 min. Coverslips were moved to fresh six-well plates and blocking was achieved by preincubation with nonspecific horse serum for 30 min at 37°C. Two primary antibodies, e.g., rabbit anti-UL97 (supplied by D. Michel, Univ. Ulm, Germany) and mouse MAb-UL44, were used for the combined incubation for 90 min at 37°C. Secondary antibodies were chosen for double-staining in green (anti-rabbit-FITC, Dianova) and red (anti-mouse-Cy3, Dianova), respectively, and incubated for 45 min at 37°C. Washing steps were performed by three incubation steps in PBS each for 10 min. Nuclear counterstaining was carried out using Vectashield mounting medium with DAPI (Vector Laboratories, Burlingame, CA).
Data for immunofluorescence were collected by the use of a Zeiss Axiovert-135 microscope at magnifications of ϫ 400 and ϫ 630. FITC and Cy3 were analyzed at at excitation wavelengths of 450 -490 and 510 -560 nm, respectively, using filter sets 10 and 14 (Zeiss, Jena, Germany). Images were recorded with a Cooled Spot Color Digital Camera (Diagnostic Instruments, Burroughs, MI) and processed by using the Metaview imaging series in combination with Adobe Photoshop and Microsoft CorelDRAW software. For double staining, the two channels were overlaid by the computer for dual images (Merge). Each experiment was repeated at least three times.
In vitro kinase assay (IVKA)
The kinase activity of pUL97 was determined in vitro after recombinant expression in transfected 293 cells as a FLAG-tagged protein and immunoprecipitation from cell lysates (MAb-FLAG M2, Sigma) as described recently (Marschall et al., 2001) . pUL44 was coexpressed in 293 cells and coimmunoprecipitated from the cell lysates to expose it directly to the in vitro kinase assays as a putative substrate of pUL97. The inhibitor of pUL97 kinase activity, indolocarbazole compound NGIC-I, was added to the kinase reaction (100 nM). Alternatively, for the coimmunoprecipitation of native viral proteins expressed during HCMV replication, HFFs were infected with strains AD169 and TB40E at an m.o.i. of 0.5 and lysed 3 days posttransfection (approximately 2.5 ϫ 10 7 cells per IVKA reaction) and lysates were subjected to the procedure described above using of 2 l of rabbit anti-UL97 antiserum (PepAs 1343; Marschall et al., 2002) .
